Home › Trial NCT05306587
Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.
- Trial IDNCT05306587
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorThomas Lund
- Enrollment40
- Start date2022-04-01
- ConditionsMultiple Myeloma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.